| Search by tag or site | Login to my blog ? Start my own blog |
![]() |
BioHealth InvestorBioHealth Investor (BHI) is a blog and journal focused on providing updated commentary and financial news from the biotech and medical technology industry. BHI's content is featured on Yahoo!Finance, Google Finance, TheStreet.com, SeekingAlpha.com and many other blogs and websites. BHI is also a proud member of The Business of Biotech Network, and the Investors Blog Network. |
Inverness Acquires Majority Stake In Diamics
Posted on 07/20/2007 03:24:34 | Link | Post Comment
by Sara Calabro
Med Tech Sentinel
Diamics, a Novato, CA-based company that develops molecular-based cancer screening and diagnostic systems, has secured a $6 million equity investment from Inverness Medical Innovations (IMA). The deal gives Inverness, a leading diagnostics company specializing in women’s health, 51% of the privately held firm.
Under the terms of the agreement, Inverness will help drive commercialization of Diamics’ products. It will provide strategic and hands-on assistance with assay development, product design, and manufacturing and distribution.
Diamics is developing products to improve the effectiveness of cervical cancer screening and to make the procedure less painful. Its FDA-cleared CerCol Cervical Cancer Collection System collects cellular and fractional histological material from the entire cervix with a single, soft-tipped device. The system is used together with Diamics’ Pap-Map system, which provides a “map” of the collected sample, to help guide physicians’ subsequent decisions about colposcopy and biopsy procedures.
Diamics’ point-of-care offering, C-Map, is in pre-clinical trials. The goal with C-Map is to create a more accurate and less costly method of screening women for precancerous conditions of the uterine cervix. The system uses automation to identify abnormalities as expressed within the context of normal cellular morphology and eliminates the need for a cell by cell analysis, yielding greater sensitivity and specificity than cytology.
“We are delighted that Inverness has acknowledged the progress of the company and the value of our novel technologies focused on improving cervical cancer screening,” said Diamics CEO Peter Gombrich, in a statement.
Med Tech Sentinel is a regular contributor to BioHealth Investor
_________________
Med Tech Sentinel
Diamics, a Novato, CA-based company that develops molecular-based cancer screening and diagnostic systems, has secured a $6 million equity investment from Inverness Medical Innovations (IMA). The deal gives Inverness, a leading diagnostics company specializing in women’s health, 51% of the privately held firm.
Under the terms of the agreement, Inverness will help drive commercialization of Diamics’ products. It will provide strategic and hands-on assistance with assay development, product design, and manufacturing and distribution.
Diamics is developing products to improve the effectiveness of cervical cancer screening and to make the procedure less painful. Its FDA-cleared CerCol Cervical Cancer Collection System collects cellular and fractional histological material from the entire cervix with a single, soft-tipped device. The system is used together with Diamics’ Pap-Map system, which provides a “map” of the collected sample, to help guide physicians’ subsequent decisions about colposcopy and biopsy procedures.
Diamics’ point-of-care offering, C-Map, is in pre-clinical trials. The goal with C-Map is to create a more accurate and less costly method of screening women for precancerous conditions of the uterine cervix. The system uses automation to identify abnormalities as expressed within the context of normal cellular morphology and eliminates the need for a cell by cell analysis, yielding greater sensitivity and specificity than cytology.
“We are delighted that Inverness has acknowledged the progress of the company and the value of our novel technologies focused on improving cervical cancer screening,” said Diamics CEO Peter Gombrich, in a statement.
Med Tech Sentinel is a regular contributor to BioHealth Investor
_________________
- Mri To Lead Growth In Medical-imaging Market
- Malaria And Hiv - Eradication And Treatment
- Dragon’s New Production Process To Cut Costs
- Mrsa Update: Cepheid, Basilea And Nektar
- If Only Us Health Care Could Be More Like The Patriots (or Even The Red Sox) And Less Like The Yankees
![]()
- Millionaire Now! by Larry Nusbaum
- Ludwig von Mises Institute
- Credit Bloggers
- Don't Mess With Taxes
- Invest2Success
- Poor and Stupid
Examples
Morpheus Trading - Mon Jul 21, 2008 08:33AM
NOTE: Please click on the charts below to enlarge them if [read more]
NOTE: Please click on the charts below to enlarge them if [read more]
Morpheus Trading - Mon Jul 21, 2008 08:31AM
NOTE: Please click on the charts below to enlarge them i [read more]
NOTE: Please click on the charts below to enlarge them i [read more]
Millionaire Now! by Larry Nusbaum - Fri Jul 18, 2008 08:23AM
U.S. stock futures rebound on Citigroup results"S&a [read more]
U.S. stock futures rebound on Citigroup results"S&a [read more]












<< My Home | TheMoneyBlogs Home